VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 111 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $252,000 | -23.6% | 17,911 | 0.0% | 0.00% | – |
| Q1 2019 | $330,000 | -9.8% | 17,911 | +28.0% | 0.00% | – |
| Q4 2018 | $366,000 | +102.2% | 13,995 | +17.6% | 0.00% | – |
| Q4 2017 | $181,000 | -15.0% | 11,896 | 0.0% | 0.00% | – |
| Q3 2017 | $213,000 | -48.6% | 11,896 | -53.1% | 0.00% | -100.0% |
| Q2 2017 | $414,000 | +16.6% | 25,373 | 0.0% | 0.00% | – |
| Q1 2017 | $355,000 | +59.2% | 25,373 | +81.6% | 0.00% | – |
| Q4 2016 | $223,000 | +25.3% | 13,973 | +12.6% | 0.00% | – |
| Q4 2014 | $178,000 | -61.3% | 12,413 | -72.0% | 0.00% | -100.0% |
| Q3 2014 | $460,000 | -35.8% | 44,313 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $717,000 | -40.8% | 44,313 | -40.5% | 0.00% | -50.0% |
| Q1 2014 | $1,211,000 | +30.9% | 74,513 | 0.0% | 0.00% | +33.3% |
| Q4 2013 | $925,000 | +140.3% | 74,513 | +112.3% | 0.00% | +200.0% |
| Q3 2013 | $385,000 | +220.8% | 35,100 | +135.6% | 0.00% | – |
| Q2 2013 | $120,000 | – | 14,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |